ACTA1 and cancer: A recent paper has unexpectedly demonstrated, in a PDAC transgenic mouse model, that depletion of α-SMA-positive and proliferating cells accelerates cancer progression, instead of stopping it, by inducing immunosuppression (Ozdemir et al, 2014).